TBA (last known deadline was November 28, 2011)
The SU2C-PCF Prostate Dream Team Translational Cancer Research Grant will provide funding of up to $10 million over a three-year period for a cancer research project that will address therapeutic interventions for advanced prostate cancer with special emphasis on metastatic disease, and deliver near-term patient benefit through investigation by a multidisciplinary, multi-institutional, synergistic Dream Team of expert investigators. Proposals for the SU2C-PCF Prostate Dream Team Translational Cancer Research Grant must include plans indicating how the work will be translated into the clinic.